
|Articles|February 15, 2022
- Pharm Exec E-Books-03-08-2021
- Volume Sponsored eBook
- Issue 2
The Next Domino: Automation, AI, and touchless safety case processing
Author(s)Oracle
With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
2
FDA Approves Yuvezzi to Treat Presbyopia in Adults
3
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
4
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
5